OPKO Health Long Term Debt 2011-2025 | OPK
OPKO Health long term debt from 2011 to 2025. Long term debt can be defined as the sum of all long term debt fields.
|
OPKO Health Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $419 |
| 2023 | $214 |
| 2022 | $210 |
| 2021 | $188 |
| 2020 | $222 |
| 2019 | $211 |
| 2018 | $57 |
| 2017 | $29 |
| 2016 | $44 |
| 2015 | $49 |
| 2014 | $131 |
| 2013 | $212 |
| 2012 | |
| 2011 | $25 |
| 2010 | |
|
OPKO Health Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2025-09-30 | $329 |
| 2025-06-30 | $326 |
| 2025-03-31 | $323 |
| 2024-12-31 | $419 |
| 2024-09-30 | $424 |
| 2024-06-30 | $176 |
| 2024-03-31 | $344 |
| 2023-12-31 | $214 |
| 2023-09-30 | $213 |
| 2023-06-30 | $212 |
| 2023-03-31 | $211 |
| 2022-12-31 | $210 |
| 2022-09-30 | $142 |
| 2022-06-30 | $211 |
| 2022-03-31 | $211 |
| 2021-12-31 | $188 |
| 2021-09-30 | $186 |
| 2021-06-30 | $183 |
| 2021-03-31 | $225 |
| 2020-12-31 | $222 |
| 2020-09-30 | $219 |
| 2020-06-30 | $216 |
| 2020-03-31 | $214 |
| 2019-12-31 | $211 |
| 2019-09-30 | $209 |
| 2019-06-30 | $206 |
| 2019-03-31 | $204 |
| 2018-12-31 | $57 |
| 2018-09-30 | $57 |
| 2018-06-30 | $56 |
| 2018-03-31 | $55 |
| 2017-12-31 | $29 |
| 2017-09-30 | $29 |
| 2017-06-30 | $35 |
| 2017-03-31 | $39 |
| 2016-12-31 | $44 |
| 2016-09-30 | $52 |
| 2016-06-30 | $45 |
| 2016-03-31 | $50 |
| 2015-12-31 | $49 |
| 2015-09-30 | $44 |
| 2015-06-30 | $109 |
| 2015-03-31 | $107 |
| 2014-12-31 | $131 |
| 2014-09-30 | $115 |
| 2014-06-30 | $116 |
| 2014-03-31 | $225 |
| 2013-12-31 | $212 |
| 2013-09-30 | $209 |
| 2013-06-30 | $189 |
| 2013-03-31 | $276 |
| 2012-12-31 | |
| 2012-09-30 | $33 |
| 2012-06-30 | $23 |
| 2012-03-31 | $22 |
| 2011-12-31 | $25 |
| 2011-09-30 | $2 |
| 2011-06-30 | $2 |
| 2011-03-31 | $2 |
| 2010-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.983B | $0.713B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $217.960B | 25.90 |
| Intuitive Surgical (ISRG) | United States | $202.722B | 79.31 |
| IDEXX Laboratories (IDXX) | United States | $56.014B | 55.63 |
| Edwards Lifesciences (EW) | United States | $49.970B | 33.51 |
| Alcon (ALC) | Switzerland | $38.774B | 26.20 |
| IQVIA Holdings (IQV) | United States | $38.071B | 21.23 |
| Mettler-Toledo (MTD) | United States | $28.849B | 33.75 |
| STERIS (STE) | Ireland | $25.561B | 26.39 |
| DexCom (DXCM) | United States | $23.292B | 32.11 |
| Waters (WAT) | United States | $22.582B | 29.87 |
| Hologic (HOLX) | United States | $16.517B | 17.39 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.201B | 0.00 |
| Globus Medical (GMED) | United States | $11.241B | 23.59 |
| Penumbra (PEN) | United States | $10.916B | 76.79 |
| Masimo (MASI) | United States | $8.188B | 26.24 |
| Sysmex ADR (SSMXY) | Japan | $6.364B | 20.22 |
| Glaukos (GKOS) | United States | $5.273B | 0.00 |
| Teleflex (TFX) | United States | $4.837B | 7.71 |
| TransMedics (TMDX) | United States | $3.949B | 46.78 |
| Veracyte (VCYT) | United States | $3.152B | 35.92 |
| LivaNova (LIVN) | United Kingdom | $3.014B | 16.28 |
| Alphatec Holdings (ATEC) | United States | $3.001B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.384B | 11.19 |
| Artivion (AORT) | United States | $2.160B | 99.11 |
| Elekta AB (EKTAY) | Sweden | $1.775B | 17.20 |
| Nihon Kohden (NHNKY) | Japan | $1.739B | 15.18 |
| PROCEPT BioRobotics (PRCT) | United States | $1.700B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.189B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.155B | 0.00 |
| AxoGen (AXGN) | United States | $1.109B | 0.00 |
| IRadimed (IRMD) | United States | $1.075B | 51.21 |
| Pulse Biosciences (PLSE) | United States | $0.958B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.938B | 5.08 |
| SiBone (SIBN) | United States | $0.749B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.594B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.545B | 10.88 |
| Tactile Systems Technology (TCMD) | United States | $0.544B | 31.65 |
| AngioDynamics (ANGO) | United States | $0.507B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.492B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.441B | 0.00 |
| NeuroPace (NPCE) | United States | $0.427B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.424B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.419B | 11.56 |
| RxSight (RXST) | United States | $0.394B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.373B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.349B | 2.63 |
| Alpha Tau Medical (DRTS) | Israel | $0.328B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.304B | 50.65 |
| Spectral Diagnostics (EDTXF) | Canada | $0.255B | 0.00 |
| CVRx (CVRX) | United States | $0.234B | 0.00 |
| 908 Devices (MASS) | United States | $0.210B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.200B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.198B | 0.00 |
| Inogen (INGN) | United States | $0.187B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.156B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.147B | 0.00 |
| Neuronetics (STIM) | United States | $0.140B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.134B | 0.00 |
| Accuray (ARAY) | United States | $0.126B | 0.00 |
| LENSAR (LNSR) | United States | $0.122B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.092B | 0.00 |
| Hyperfine (HYPR) | United States | $0.083B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.079B | 0.00 |
| InspireMD (NSPR) | United States | $0.079B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.073B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.072B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Spectral AI (MDAI) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.046B | 0.00 | |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| DarioHealth (DRIO) | United States | $0.023B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.021B | 0.00 |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.015B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.010B | 0.00 |
| Solana (HSDT) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.005B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.39 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |